
Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s
Capton® Platform Paves the Way for Onsite Drug Synthesis That Could Revolutionize Neurology SAN FRANCISCO, CA, UNITED STATES, March 24, 2025 /EINPresswire.com/ -- Enabled Therapeutics, a precision neurology company, today announced the …